Funder: Breakthrough T1D
Due Dates: November 5, 2026 (Round 1 LOI) | December 17, 2026 (Round 1 notification) | May 6, 2027 (Round 2 LOI) | June 17, 2027 (Round 2 notification)
Funding Amounts: Budget and project duration approved individually for each application
Summary: Supports research concepts aligned with Breakthrough T1D’s Research Strategy to address critical gaps in type 1 diabetes research.
Key Information: An approved Letter of Intent and invitation are required before submitting a full proposal.
Description
Project Concepts is Breakthrough T1D’s semi-annual opportunity to submit Letters of Intent for Strategic Research Agreements (SRAs). These agreements support investigators addressing critical gaps and challenges in type 1 diabetes research through cutting-edge scientific investigation. Concepts must address the funder’s current Research Strategy, whose two pillars are curing T1D and improving the lives of people with T1D. Priorities include early detection, disease-modifying therapies, beta cell replacement, and reducing disease burden and complications.
An SRA is a partnership between investigators and Breakthrough T1D scientists, involving cooperative development of the research plan and ongoing interaction during the award. Full proposals are invited based on programmatic fit and the robustness of the concept. Projects with prospects for transformative breakthroughs to prevent, treat, or cure T1D receive top priority.
